Showing 1 to 10 of 15 results
Two biotech start-ups incubated by CityU have been selected for the “Forbes Asia 100 to Watch 2023”, an annual list published by Forbes Asia highlighting small companies and start-ups on the rise across the Asia Pacific region that are targeting underserved markets with new technologies.
Eminent scholars explored complex signaling networks in various metabolic pathways at the HK Tech Forum on Metabolism in Health and Disease from 15 to 16 December.
The key takeaway from the recent talk by Professor Huang Yu at CityU was something we could easily relate to: keep your blood vessels healthy.
Researchers at CityU received tremendous accolades at Inventions Geneva Evaluation Days (IGED) 2022 by winning a total of 22 awards, the highest number among local institutions for two years in a row.
A research team at CityU has developed the first mathematical model that takes variation in confirmation delay into account, making quantifying the impacts of non-pharmaceutical interventions (NPIs) such as gathering bans more accurate.
Five faculty members at CityU are conferred the Outstanding Research Award this year for their eminent performances in materials science, media and communication, biomedical sciences and data science.
One Health @ CityU x France has brought together professionals from various areas of expertise to discuss biotechnology and the contribution of veterinary medicine and engineering to the “One Health” approach in two panel discussions.
Professor Sun Dong, Chair Professor and Head of the Department Biomedical Engineering at CityU, has been elected a Member of the European Academy of Sciences and Arts in the Technical and Environmental Sciences class.
Researchers from CityU won the highest number of awards among all universities in Hong Kong at IGED 2021, including a Gold Medal with Congratulations of the Jury, five Gold Medals, three Silver Medals and three Bronze Medals, demonstrating the excellence of the research carried out at CityU.
Research at CityU aimed at tackling Covid-19 has attracted over $7.1 million in funding from the Innovation and Technology Fund (ITF) under the Innovation and Technology Commission.